BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS ...Middle East

Meeting will take place on December 6; Company plans to seek Special Protocol Assessment (SPA) NEW YORK, Nov. 20, 2023 /PRNewswire/ --BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that...

Hence then, the article about brainstorm cell therapeutics announces in person meeting with the fda to discuss confirmatory phase 3 trial for nurown in als was published today ( Monday 20/11/2023 - 04:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS )

Also on site :

• 1999 Box Office Flop Ranked Among ‘Best Movies of All Time’
• Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets
• Carrie Underwood Fans Do a Double Take at Her New Look Ahead of Taylor Swift Night on 'American Idol'